Dr. Michelle Berrey

Independent Director

M.D. Medical College of Georgia
M.P.H. from the Emory University Rollins School of Public Health

Dr. Berrey currently serves on the Board and Executive Committee for the North Carolina Biotechnology Center and is on the Scientific Advisory Board for ViiV/GSK.

Dr. Berrey served as President and Chief Executive Officer of Chimerix (Nasdaq: CMRX) from April 2014 to February 2019, after joining Chimerix as Chief Medical Officer in November 2012. Dr. Berrey served as Chief Medical Officer for Pharmasset, Inc. (Nasdaq: VRUS) from January 2007 to January 2012 when it was acquired by Gilead (Nasdaq: GILD).

Prior to that, Dr. Berrey led the clinical development of antiviral products at GlaxoSmithKline from August 1999 to January 2007. She was a Senior Fellow in Infectious Disease Medicine at the University of Washington and completed her internship and residency in internal medicine at University of North Carolina, Chapel Hill.